Shift towards minimally invasive spine surgery (MIS) poses lucrative opportunities for key players in the spinal implants and devices market. MIS is preferred due to several benefits such as it does not involve a long cut or incision, which in turn reduces the chances of damage caused to the muscles surrounding the spine.
The global spinal implants and devices market was worth $9,741 million in 2015, and is estimated to reach $13,384 million by 2022, growing at a CAGR of 4.6% during the study period. Spinal implants and devices are used to treat spinal deformities such as spinal stenosis and isthmic spondylolisthesis. Increase in geriatric population, rise in adoption of minimal invasive surgery techniques, and upsurge in incidence rate of spinal disorders are expected to drive the market growth. Moreover, technological advancements in spinal fusion implants fuel this growth. However, unfavorable reimbursement scenario and stringent regulatory approval procedures are expected to impede the market growth.
Spinal stenosis is the most common problem in men and women over 50 years of age. With age, changes occur in the structure of the spine, such as the band of the tissue that supports the spine gets thick, bones and joints get bigger, thus leading to the most common cause of spinal impairment. According to Eurostat, on January 1, 2015, the European Union (EU)-28 population was estimated to be 508.5 million of which older persons (aged 65 years or over) had an 18.9% share, reflecting an increase of 0.4% compared to the previous year. Therefore, increase in geriatric population is expected to impact the demand for spinal implant and devices for the treatment of spinal disorders.
Get the PDF brochure of this market insight@ https://www.alliedmarketresearch.com/request-sample/1620
Spinal fusion implants are expected to dominate the market throughout the analysis period, owing to various advancements such as the advent of hook, rod and screw systems, which allow surgeons to correct spinal deformities in a three-dimensional way, and the development of special plates and cages that promote spinal fusion.
Based on surgery, open spine surgery generated maximum revenue, accounting for almost two-third of the global spinal implants and devices market in 2015. However, the minimally invasive surgery market is estimated to exhibit the highest growth rate of 14.7% during the forecast period.
Do Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/1620
Asia-Pacific is projected to grow at the highest CAGR of 5.7% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (India and China) to overcome the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for market growth.
The major companies profiled in the report include Alphatec Holdings, Inc., B. Braun Melsungen AG, Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc.